Home' Australian Pharmacist : Australian Pharmacist December 2012 Contents 920 Australian Pharmacist December 2012 I ©Pharmaceutical Society of Australia Ltd.
Australian Pharmacist has been
recognised in Australia's top
PSA's official journal was runner-up
in the Association or Member
Organisation Magazine of the Year
section of the annual Publishers Australia
PSA CEO Liesel Wett said that the
Awards gave Australian Pharmacist an
opportunity to compare itself with the
wider publishing industry.
'This is proof from the publishing industry
that PSA's journal is a quality product that
all PSA members can be proud of. This is
shown by the judges' comments -- "Well
designed for the readership. High quality
editorial. Makes a dry topic engaging.
'The fact that Australian Pharmacist
showed itself to be competitive in
a national competition beyond the
boundaries of pharmacy is a credit to
all of the PSA staff and the authors who
contribute to it. Special mention should
go to Graphic Designer, Rebecca Jones
and Editor Andrew Daniels,' she said.
Australian Pharmacist was beaten for
the top spot by the Medibank Private
Magazine of the year awards in other
categories were, Donna Hay, Dirt Action,
Adelaide Hills Magazine, INTHEBLACK, and
The Advisor. The website of the year was
won by Mumbrella.
The health and medical research
industry need to further empower and
share information with the community
according the consumer polling released
by Research Australia last month.
The survey shows 59% of Australians
would be open to participating in clinical
trials if they had a relevant medical
condition, a figure that has remained
constant over eight years. Significantly,
however, interest has grown in those
who are unsure, but would consider
participating in clinical trials if they had
more information (from 21% to 37%).
The number who would definitely not
participate in a clinical trial has fallen
from 20% to only 4%.
Research Australia's annual survey of
more than 1,000 Australians investigates
current public opinions on health and
medical research and related policy.
Elizabeth Foley, Chief Executive Officer
of Research Australia said, 'the need
for a more empowered and informed
community is one of Research Australia's
key strategic imperatives. We need to
empower the people by telling them
more about what the medical research
is for, and to foster greater value and
understanding within the community of
health and medical research.
'The community wants more information
and engagement, which has come
through in the public submissions made
by consumer health organisations to the
'Clinical trials are essential in translating
basic research into something that will
change people's lives for the better. The
sector needs to partner with 'patients'
more, and ensure that we are integrating
health and medical research into the
health care system,' she said.
'The new clinical trials website (at: www.
by the Australian Government last month,
is a step in the right direction!'
1. Strategic Review of Health and Medical Research in Australia
Green light for MA Code
Medicines Australia (MA) has welcomed
a draft determination by the ACCC to
authorise edition 17 of the Medicines
Australia Code of Conduct.
MA Chief Executive, Dr Brendan Shaw
said 'We are pleased that the ACCC
acknowledges the new provisions in
the Code which are major shift towards
greater transparency, ensure appropriate
interactions between companies and
healthcare professionals and which
provide greater clarity around the
application of the Code.
'Our extensive consultation with
consumer organisations, academics, peak
doctor groups and other stakeholders
have strengthened the Code for the
better. We are particularly pleased
that the ACCC acknowledges sectoral
leadership by MA in convening a multi-
stakeholder transparency working group.
This group will examine and report on
appropriate ways to disclose payments to
healthcare professionals at an individual
level. Industry will play its part toward
devising a constructive and effective
solution for consumers on this issue,' he
The ACCC has requested further
information from Medicines Australia
on three matters: publication of reports
in a searchable format, whether the
complaints process could be made
more accessible for individuals and
potential inclusion of representatives of
consumer and healthcare professionals
on the Code Review Panel. The new
Code of Conduct is available at: www.
The Multiple morbidities: How pharmacists
can make a difference through medication
reviews training module for accredited
pharmacists was announced at the AACP
Accredited Pharmacist Forum at PAC 2012
in late October.
The module outlines a number of
strategies and recommendations to help
patients who have multiple morbidities.
Module author Debbie Rigby, Consultant
Clinical Pharmacist and Accredited
Pharmacist, said, 'Home Medicines
PRINT POST APPROVED
AUSTR ALIA'S M OS
AUSTRALIA'S MOST CLOSELY RE AD PHARMACY JOURNAL
Links Archive Australian Pharmacist January 2013 Australian Pharmacist November 2012 Navigation Previous Page Next Page